EMA drafts guidance on duplicate ADR reports
This article was originally published in Scrip
Executive Summary
The European Medicines Agency has published draft guidance intended to help regulatory authorities detect and deal with duplicate ADR reports.
You may also be interested in...
Ireland Embarks On New Stage Of Drug Verification System
The bedding-in period is ending for Europe’s one-year-old system for preventing the circulation of fake medicines, and the scheme is gearing up for a more fully operational stage.
EU & US At Odds Over Merck’s Keytruda
EU and US regulators have opposing views when it comes to Merck's applications for a new indication and new dosing schedule for the company's successful PD-1 inhibitor Keytruda.
First African Approvals For Merck’s Ebola Vaccine
Regulators have pulled out all the stops in their efforts to get the Ebola vaccine to the marketing authorization stage in Africa.
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports